Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research CNS/Neurology Market Research

Nanotechnology Drug Delivery Market (Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; and Application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global I

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 120 Pages Transparency Market Research Pvt. Ltd. February, 2022 TNPR17067641
Best Price Guarantee
Price from $5,795
Length 120 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date February, 2022
SKU TNPR17067641

Nanotechnology Drug Delivery Market (Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; and Application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Nanotechnology Drug Delivery Market – Scope of Report
TMR’s report on the global nanotechnology drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global nanotechnology drug delivery market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nanotechnology drug delivery market from 2021 to 2028.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the nanotechnology drug delivery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nanotechnology drug delivery market.

The report includes an elaborate executive summary along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nanotechnology drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nanotechnology drug delivery market.

The report delves into the competition landscape of the global nanotechnology drug delivery market. Key players operating in the global nanotechnology drug delivery market have been identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nanotechnology drug delivery market profiled in this report.

Key Questions Answered in Nanotechnology Drug Delivery Market Report
What is the sales/revenue generated by nanotechnology drug delivery suppliers/manufacturers across all countries during the forecast period?
What are the key trends in the global nanotechnology drug delivery market?
What are the major drivers, restraints, and opportunities in the market?
Which country/sub-region is set to expand at the fastest CAGR during the forecast period?
Which nanotechnology drug delivery segment will have the highest revenue in 2028 and which segment will grow at the highest CAGR during the forecast period?
Nanotechnology Drug Delivery Market – Research Objectives and Research Approach
The comprehensive report on the global nanotechnology drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nanotechnology drug delivery market in terms of technology, application, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2028 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nanotechnology drug delivery market.

Companies Mentioned

AbbVie, Inc.
Amgen, Inc.
Celgene Corporation
Johnson & Johnson
Merck & Co., Inc.
Perrigo Company plc
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd."


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nanotechnology Drug Delivery Market
4. Market Overview
4.1. Introduction
4.1.1. Technology Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nanotechnology Drug Delivery Market Analysis and Forecast, 2017–2028
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. Covid-19 Impact Analysis
6. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Technology, 2017–2028
6.3.1. Nanocrystals
6.3.2. Nanoparticles
6.3.2.1. Dendrimers
6.3.2.2. Gold Nanoparticles
6.3.2.3. Fullerenes
6.3.2.4. Others
6.3.3. Liposomes
6.3.4. Micelles
6.3.5. Nanotubes
6.3.6. Others
6.4. Market Attractiveness Analysis, by Technology
7. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value & Volume Forecast, by Application, 2017–2028
7.3.1. Neurology
7.3.2. Oncology
7.3.3. Cardiovascular/Physiology
7.3.4. Anti-inflammatory/Immunology
7.3.5. Anti-infective
7.3.6. Others (hematology, ophthalmology, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value & Volume Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Country/Region
9. North America Nanotechnology Drug Delivery Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value & Volume Forecast, by Technology, 2017–2028
9.2.1. Nanocrystals
9.2.2. Nanoparticles
9.2.2.1. Dendrimers
9.2.2.2. Gold Nanoparticles
9.2.2.3. Fullerenes
9.2.2.4. Others
9.2.3. Liposomes
9.2.4. Micelles
9.2.5. Nanotubes
9.2.6. Others
9.3. Market Value & Volume Forecast, by Application, 2017–2028
9.3.1. Neurology
9.3.2. Oncology
9.3.3. Cardiovascular/Physiology
9.3.4. Anti-inflammatory/Immunology
9.3.5. Anti-infective
9.3.6. Others (hematology, ophthalmology, etc.)
9.4. Market Value & Volume Forecast, by Country, 2017–2028
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Technology
9.5.2. By Application
9.5.3. By Country
10. Europe Nanotechnology Drug Delivery Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Technology, 2017–2028
10.2.1. Nanocrystals
10.2.2. Nanoparticles
10.2.2.1. Dendrimers
10.2.2.2. Gold Nanoparticles
10.2.2.3. Fullerenes
10.2.2.4. Others
10.2.3. Liposomes
10.2.4. Micelles
10.2.5. Nanotubes
10.2.6. Others
10.3. Market Value & Volume Forecast, by Application, 2017–2028
10.3.1. Neurology
10.3.2. Oncology
10.3.3. Cardiovascular/Physiology
10.3.4. Anti-inflammatory/Immunology
10.3.5. Anti-infective
10.3.6. Others (hematology, ophthalmology, etc.)
10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Technology
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Nanotechnology Drug Delivery Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Technology, 2017–2028
11.2.1. Nanocrystals
11.2.2. Nanoparticles
11.2.2.1. Dendrimers
11.2.2.2. Gold Nanoparticles
11.2.2.3. Fullerenes
11.2.2.4. Others
11.2.3. Liposomes
11.2.4. Micelles
11.2.5. Nanotubes
11.2.6. Others
11.3. Market Value & Volume Forecast, by Application, 2017–2028
11.3.1. Neurology
11.3.2. Oncology
11.3.3. Cardiovascular/Physiology
11.3.4. Anti-inflammatory/Immunology
11.3.5. Anti-infective
11.3.6. Others (hematology, ophthalmology, etc.)
11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Technology
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Nanotechnology Drug Delivery Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Technology, 2017–2028
12.2.1. Nanocrystals
12.2.2. Nanoparticles
12.2.2.1. Dendrimers
12.2.2.2. Gold Nanoparticles
12.2.2.3. Fullerenes
12.2.2.4. Others
12.2.3. Liposomes
12.2.4. Micelles
12.2.5. Nanotubes
12.2.6. Others
12.3. Market Value & Volume Forecast, by Application, 2017–2028
12.3.1. Neurology
12.3.2. Oncology
12.3.3. Cardiovascular/Physiology
12.3.4. Anti-inflammatory/Immunology
12.3.5. Anti-infective
12.3.6. Others (hematology, ophthalmology, etc.)
12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Technology
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Nanotechnology Drug Delivery Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Technology, 2017–2028
13.2.1. Nanocrystals
13.2.2. Nanoparticles
13.2.2.1. Dendrimers
13.2.2.2. Gold Nanoparticles
13.2.2.3. Fullerenes
13.2.2.4. Others
13.2.3. Liposomes
13.2.4. Micelles
13.2.5. Nanotubes
13.2.6. Others
13.3. Market Value & Volume Forecast, by Application, 2017–2028
13.3.1. Neurology
13.3.2. Oncology
13.3.3. Cardiovascular/Physiology
13.3.4. Anti-inflammatory/Immunology
13.3.5. Anti-infective
13.3.6. Others (hematology, ophthalmology, etc.)
13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Technology
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2020
14.3. Market Footprint Analysis
14.3.1. By Region
14.3.2. By Technology
14.3.3. By Application
14.4. Competitive Business Strategies
14.5. Company Profiles
14.5.1. AbbVie, Inc.
14.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.1.2. Product Portfolio
14.5.1.3. SWOT Analysis
14.5.1.4. Strategic Overview
14.5.2. Amgen, Inc.
14.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.2.2. Product Portfolio
14.5.2.3. SWOT Analysis
14.5.2.4. Strategic Overview
14.5.3. Celgene Corporation
14.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.3.2. Product Portfolio
14.5.3.3. SWOT Analysis
14.5.3.4. Strategic Overview
14.5.4. Johnson & Johnson
14.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.4.2. Product Portfolio
14.5.4.3. SWOT Analysis
14.5.4.4. Strategic Overview
14.5.5. Merck & Co., Inc.
14.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.5.2. Product Portfolio
14.5.5.3. SWOT Analysis
14.5.5.4. Strategic Overview
14.5.6. Perrigo Company plc
14.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.6.2. Product Portfolio
14.5.6.3. SWOT Analysis
14.5.6.4. Strategic Overview
14.5.7. Pfizer, Inc.
14.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.7.2. Product Portfolio
14.5.7.3. SWOT Analysis
14.5.7.4. Strategic Overview
14.5.8. Teva Pharmaceutical Industries Ltd.
14.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.5.8.2. Product Portfolio
14.5.8.3. SWOT Analysis
14.5.8.4. Strategic Overview
14.5.9. Other players

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings